Definitive Healthcare Corp. (DH) stock plummeted by 9.6% in Monday's intraday trading session, following a price target cut by analysts at Deutsche Bank.
According to a research note from Deutsche Bank, the bank lowered its price target on Definitive Healthcare shares from $5 to $4, while maintaining a "Hold" rating on the stock.
The price target reduction reflects analysts' concerns about the company's prospects and future performance, which contributed to the sharp sell-off in Definitive Healthcare's stock price on Monday.